Healthcare & Life Sciences
Sanacor
About
Sanacor develops therapies targeting the reversal of diseases caused by Fis1 overexpression, with its lead program focused on treating diabetic cardiovascular disease.
Explore Sanacor's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.